Anzeige
Mehr »
Login
Samstag, 19.04.2025 Börsentäglich über 12.000 News von 690 internationalen Medien
Trumps Dekret beschleunigt Antimon-Boom - Wird Global Tactical der nächste Highflyer für kritische Mineralien?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

GlobeNewswire (Europe)-Archiv vom 22.04.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
22.04.24XMReality AB: XMReality Interim report Group overview, January - March 2024154Total order intake for Q1 2024 has increased by 54 percent compared to Q1 2023. However, net sales was down year-over-year, and the company's ARR was also down somewhat, both as a result of continued...
► Artikel lesen
22.04.24CIECH Group will change its name to Qemetica in June356In June, the name of the CIECH Group companies will change. The abbreviation CIECH will be replaced by the new name: Qemetica. The planned change is a further consistent step in the Group's chemical...
► Artikel lesen
22.04.24Generation Bio Co.: Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting197CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, today...
► Artikel lesen
22.04.24Cidara Therapeutics, Inc.: Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results262SAN DIEGO, April 22, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate...
► Artikel lesen
22.04.24Cidara Therapeutics, Inc.: Cidara Therapeutics Announces Receipt of Nasdaq Delinquency Notice394SAN DIEGO, April 22, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate...
► Artikel lesen
22.04.24Brown & Brown, Inc. announces first quarter 2024 results, including total revenues of $1,258 million, an increase of 12.7%; Organic Revenue growth of 8.6%; diluted net income per share of $1.02; Diluted Net Income Per Share - Adjusted of $1.14; and a quar127DAYTONA BEACH, Fla., April 22, 2024 (GLOBE NEWSWIRE) -- Brown & Brown, Inc. (NYSE:BRO) (the "Company") announced its unaudited financial results for the first quarter of 2024. Revenues for the first...
► Artikel lesen
22.04.24SmartFinancial, Inc.: SmartFinancial Announces Results for the First Quarter 2024203KNOXVILLE, Tenn., April 22, 2024 (GLOBE NEWSWIRE) -- SmartFinancial, Inc. ("SmartFinancial" or the "Company"; NYSE: SMBK), today announced net income of $9.4 million, or $0.55 per diluted common share...
► Artikel lesen
22.04.24Scorpius Holdings, Inc.: Scorpius Holdings Announces Receipt of Filing Delinquency Notification498DURHAM, N.C., April 22, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX), an integrated contract development and manufacturing organization (CDMO), received an official notice...
► Artikel lesen
22.04.24First Bank Announces First Quarter 2024 Net Income of $12.5 Million547HAMILTON, N.J., April 22, 2024 (GLOBE NEWSWIRE) -- First Bank (Nasdaq Global Market: FRBA) (the Bank) today announced results for the first quarter of 2024. Net income for the first quarter of 2024...
► Artikel lesen
22.04.24iLearningEngines Holdings, Inc.: iLearningEngines Reports Fourth Quarter and Full Year 2023 Results210Fourth quarter revenue grew 39% year-over-year to $116 million Posts record full year revenue of $421 million, up 36% year-over-year, and ARR growth accelerates to 43% year-over-year BETHESDA, Md....
► Artikel lesen
22.04.24Fate Therapeutics, Inc.: Fate Therapeutics Announces Presentation of FT819 Proof-of-Concept Data for B cell-mediated Autoimmune Diseases at ASGCT Annual Meeting285Key Therapeutic Mechanisms of Clinical Activity for Autoimmune Diseases, including B cell Depletion, Tissue Infiltration and Immune Reconstitution Data, from Phase 1 Study of FT819 in Relapsed / Refractory...
► Artikel lesen
22.04.24BIO-key International, Inc. Receives Notice of Non-Compliance from Nasdaq246HOLMDEL, N.J., April 22, 2024 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring...
► Artikel lesen
22.04.24Vertex Inc.: Vertex Provides Preliminary Financial Results for First Quarter 2024 and Announces First Quarter Earnings Call Date316KING OF PRUSSIA, Pa., April 22, 2024 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX), a leading global technology provider of indirect tax solutions, today announced preliminary financial results for...
► Artikel lesen
22.04.24Oportun Financial Corporation: Oportun Announces Preliminary Q1 2024 Financial Information437SAN CARLOS, Calif., April 22, 2024 (GLOBE NEWSWIRE) -- Oportun Financial Corporation ("Oportun" or the "Company") (Nasdaq: OPRT), a mission-driven fintech, today announced certain preliminary unaudited...
► Artikel lesen
22.04.24NBT Bancorp Inc. Announces First Quarter 2024 Results319NORWICH, N.Y., April 22, 2024 (GLOBE NEWSWIRE) -- NBT Bancorp Inc. ("NBT" or the "Company") (NASDAQ: NBTB) reported net income and diluted earnings per share for the three months ended March 31, 2024....
► Artikel lesen
22.04.24Critical Metals Corp: Critical Metals Appoints Tony Sage as Chief Executive Officer256Dietrich Wanke named President of European Operations to operationalize the Wolfsberg Lithium Project, a cornerstone asset for Europe's electric vehicle industry Joint Venture with the Obeikan Investment...
► Artikel lesen
22.04.24Capital Bancorp, Inc. Reports First Quarter 2024 Results581Net Income of $6.6 million, or $0.47 per share. Net Income, as adjusted(1) of $7.1 million, or $0.51 per shareROAA of 1.15% and ROAE of 10.19% for 1Q 2024Adjusted Metrics(1) excluding Merger-Related...
► Artikel lesen
22.04.24Pyrophyte Acquisition Corp. Receives NYSE Notice Regarding Delayed Form 10-K Filing50HOUSTON, TEXAS, April 22, 2024 (GLOBE NEWSWIRE) -- Pyrophyte Acquisition Corp. (NYSE: PHYT) (the "Company") today announced that it received a notice from the New York Stock Exchange (the "NYSE")...
► Artikel lesen
22.04.24Abeona Therapeutics Inc.: Abeona Therapeutics Provides Regulatory Update on Pz-cel184Receives FDA Complete Response Letter (CRL) based on need for additional CMC information CRL did not identify deficiencies related to clinical efficacy or clinical safety data in BLA, and no new...
► Artikel lesen
22.04.24Clover Health Investments, Corp.: Clover Health Appoints Healthcare Technology Veteran Peter Kuipers as Chief Financial Officer365FRANKLIN, Tenn., April 22, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) ("Clover," "Clover Health" or the "Company"), a physician enablement technology company, today announced...
► Artikel lesen
Seite:  Weiter >>